Novavax, Inc. (NASDAQ:NVAX)’s traded shares stood at 3.53 million during the last session, with the company’s beta value hitting 2.06. At the close of trading,
Novavax, Inc. (NASDAQ:NVAX)’s traded shares stood at 3.33 million during the last session, with the company’s beta value hitting 2.04. At the close of trading,
In the last trading session, 7.03 million Novavax, Inc. (NASDAQ:NVAX) shares changed hands as the company’s beta touched 2.04. With the company’s per share price
In last trading session, Novavax, Inc. (NASDAQ:NVAX) saw 9.84 million shares changing hands with its beta currently measuring 2.04. Company’s recent per share price level
In last trading session, Novavax, Inc. (NASDAQ:NVAX) saw 32.27 million shares changing hands with its beta currently measuring 2.05. Company’s recent per share price level
Novavax, Inc. (NASDAQ:NVAX) has a beta value of 2.05 and has seen 5.75 million shares traded in the last trading session. The company, currently valued
During the last session, Novavax, Inc. (NASDAQ:NVAX)’s traded shares were 4.46 million, with the beta value of the company hitting 2.05. At the end of
During the recent session, Novavax, Inc. (NASDAQ:NVAX)’s traded shares were 1.17 million, with the beta value of the company hitting 2.05. At the last check
In the last trading session, 4.57 million shares of the Novavax, Inc. (NASDAQ:NVAX) were traded, and its beta was 2.05. Most recently the company’s share
In the last trading session, 7.51 million shares of the Novavax, Inc. (NASDAQ:NVAX) were traded, and its beta was 2.03. Most recently the company’s share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
